# Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

> **NCT05823584** · — · COMPLETED · sponsor: **TCM Biotech International Corp.** · enrollment: 207 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05823584
- **Lead sponsor:** TCM Biotech International Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-22
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-12-31
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2024-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823584, "Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05823584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*